Hopium (ALHPI) 주식 개요호피움 SA는 프랑스에서 수소차 제조 및 판매 사업을 하고 있습니다. 자세히 보기ALHPI 펀더멘털 분석스노우플레이크 점수가치 평가2/6미래 성장0/6과거 실적3/6재무 건전성1/6배당0/6강점주가수익률(0.1x)이 French 시장(15.7x)보다 낮습니다.올해부터 흑자전환위험 분석부채는 operating cash flow로 충분히 감당되지 않습니다.의미 있는 시가총액이 없습니다(€2M)마이너스 주주 지분지난 1년 동안 주주가 크게 희석되었습니다.+ 위험 1건 추가모든 위험 점검 보기ALHPI Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW496,135 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINROAG496,135 investors already sharing narrativesYour Fair Value€Current Price€0.00442.3% 고평가 내재 할인율Growth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-31m78m2016201920222025202620282031Revenue €65.5mEarnings €78.2mAdvancedSet Fair ValueView all narrativesHopium SA 경쟁사TriganoSymbol: ENXTPA:TRIMarket cap: €2.9bGarinSymbol: WSE:GARMarket cap: zł35.1mMercury Ev-TechSymbol: BSE:531357Market cap: ₹6.7bDelfingen Société AnonymeSymbol: ENXTPA:ALDELMarket cap: €77.2m가격 이력 및 성과Hopium 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가€0.004452주 최고가€0.09552주 최저가€0.0043베타0.461개월 변동-6.38%3개월 변동-45.00%1년 변동-72.50%3년 변동-99.90%5년 변동-99.90%IPO 이후 변동-99.90%최근 뉴스 및 업데이트공고 • May 21Hopium SA, Annual General Meeting, Jun 29, 2026Hopium SA, Annual General Meeting, Jun 29, 2026. Location: 38 rue laffitte, paris FranceNew Risk • Nov 15New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (51% average weekly change). Negative equity (-€36m). Earnings have declined by 15% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 34x increase in shares outstanding). Revenue is less than US$1m (€21k revenue, or US$24k). Market cap is less than US$10m (€1.58m market cap, or US$1.84m). Minor Risk Latest financial reports are more than 6 months old (reported December 2024 fiscal period end).공고 • May 22Hopium SA, Annual General Meeting, Jun 06, 2025Hopium SA, Annual General Meeting, Jun 06, 2025. Location: u 30 rue du chateau des rentiers, paris FranceReported Earnings • May 05Full year 2024 earnings releasedFull year 2024 results: Net loss: €10.5m (loss narrowed 66% from FY 2023).New Risk • Sep 16New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€9.2m free cash flow). Share price has been highly volatile over the past 3 months (21% average weekly change). Negative equity (-€36m). Revenue has declined by 100% over the past year. Shareholders have been substantially diluted in the past year (over 17x increase in shares outstanding). Revenue is less than US$1m (€13k revenue, or US$14k). Market cap is less than US$10m (€5.48m market cap, or US$6.08m). Minor Risk Latest financial reports are more than 6 months old (reported December 2023 fiscal period end).공고 • May 26Hopium SA, Annual General Meeting, Jun 27, 2024Hopium SA, Annual General Meeting, Jun 27, 2024. Location: 7 rue auber, paris France더 많은 업데이트 보기Recent updates공고 • May 21Hopium SA, Annual General Meeting, Jun 29, 2026Hopium SA, Annual General Meeting, Jun 29, 2026. Location: 38 rue laffitte, paris FranceNew Risk • Nov 15New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (51% average weekly change). Negative equity (-€36m). Earnings have declined by 15% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 34x increase in shares outstanding). Revenue is less than US$1m (€21k revenue, or US$24k). Market cap is less than US$10m (€1.58m market cap, or US$1.84m). Minor Risk Latest financial reports are more than 6 months old (reported December 2024 fiscal period end).공고 • May 22Hopium SA, Annual General Meeting, Jun 06, 2025Hopium SA, Annual General Meeting, Jun 06, 2025. Location: u 30 rue du chateau des rentiers, paris FranceReported Earnings • May 05Full year 2024 earnings releasedFull year 2024 results: Net loss: €10.5m (loss narrowed 66% from FY 2023).New Risk • Sep 16New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€9.2m free cash flow). Share price has been highly volatile over the past 3 months (21% average weekly change). Negative equity (-€36m). Revenue has declined by 100% over the past year. Shareholders have been substantially diluted in the past year (over 17x increase in shares outstanding). Revenue is less than US$1m (€13k revenue, or US$14k). Market cap is less than US$10m (€5.48m market cap, or US$6.08m). Minor Risk Latest financial reports are more than 6 months old (reported December 2023 fiscal period end).공고 • May 26Hopium SA, Annual General Meeting, Jun 27, 2024Hopium SA, Annual General Meeting, Jun 27, 2024. Location: 7 rue auber, paris FranceReported Earnings • Apr 24Full year 2023 earnings releasedFull year 2023 results: Net loss: €30.7m (loss widened 28% from FY 2022).New Risk • Jan 25New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 118% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Negative equity (-€32m). Revenue has declined by 30% over the past year. Shareholders have been substantially diluted in the past year (118% increase in shares outstanding). Market cap is less than US$10m (€1.96m market cap, or US$2.14m). Minor Risk Revenue is less than US$5m (€2.0m revenue, or US$2.2m).New Risk • Nov 10New major risk - Revenue and earnings growthRevenue has declined by 30% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Negative equity (-€32m). Revenue has declined by 30% over the past year. Market cap is less than US$10m (€1.95m market cap, or US$2.08m). Minor Risks Shareholders have been diluted in the past year (46% increase in shares outstanding). Revenue is less than US$5m (€2.0m revenue, or US$2.1m).New Risk • Jul 31New major risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €9.08m (US$10.0m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Negative equity (-€10m). Minor Risks Shareholders have been diluted in the past year (11% increase in shares outstanding). Revenue is less than US$5m (€4.0m revenue, or US$4.4m). Market cap is less than US$100m (€9.08m market cap, or US$10.0m).공고 • Dec 01Hopium Société anonyme (ENXTPA:MLHPI) acquired Young Innovative Company.Hopium Société anonyme (ENXTPA:MLHPI) acquired Young Innovative Company on November 30, 2021. Hopium Société anonyme (ENXTPA:MLHPI) completed the acquisition of Young Innovative Company on November 30, 2021.공고 • Jun 18Hopium Unveils Its Hydrogen-powered Sedan Prototype And Opens The First 1000 Pre-ordersHopium unveiled its very first rolling prototype during the Viva Technology week in Paris. Announced in October 2020 and produced in record time in the Linas-Montlhéry test workshop, this vehicle called Alpha 0, certifies the reliability of the fuel cell system. After the design and architecture phases, followed by the implementation of the various components within the vehicle, the prototype was able to be evaluated and perfected through bench and track tests. With a speed of 200 km/h (124 mph), this test version already borders on the performance promised by the Hopium Machina in its final form. Alpha 0 also introduces for the first time the signature lighting, emblem of Hopium, whose shape is reminiscent of the stratification of hydrogen and the movement of waves on the surface of water. The reveal of this technological showcase is a key step in the manufacturer's roadmap and confirms its ability to achieve the goals that have been set and meet the high challenges. It is accompanied by the opening of an order book for the first 1,000 numbered units of Hopium Machina, whose reservation price is set at 410 euros, in reference to the spectral line of hydrogen. The Hopium teams are already fully committed in carrying out the next steps, aiming to produce Hopium Machina on an industrial scale, with a new rendez-vous expected in the first quarter of 2022.주주 수익률ALHPIFR AutoFR 시장7D-8.3%0.6%-0.1%1Y-72.5%-18.7%3.5%전체 주주 수익률 보기수익률 대 산업: ALHPI은 지난 1년 동안 -18.7%의 수익을 기록한 French Auto 산업보다 저조한 성과를 냈습니다.수익률 대 시장: ALHPI은 지난 1년 동안 3.5%를 기록한 French 시장보다 저조한 성과를 냈습니다.주가 변동성Is ALHPI's price volatile compared to industry and market?ALHPI volatilityALHPI Average Weekly Movement11.7%Auto Industry Average Movement4.4%Market Average Movement4.7%10% most volatile stocks in FR Market10.3%10% least volatile stocks in FR Market2.3%안정적인 주가: ALHPI의 주가는 지난 3개월 동안 French 시장보다 변동성이 컸습니다.시간에 따른 변동성: ALHPI의 주간 변동성은 지난 1년간 48%에서 12%로 감소했지만 여전히 French 종목의 상위 75%보다 높습니다.회사 소개설립직원 수CEO웹사이트201928Stephane Rabatelwww.hopium.com호피움 SA는 프랑스에서 수소차 제조 및 판매 사업을 하고 있습니다. 이 회사는 2019년에 설립되었으며 프랑스 파리에 본사를 두고 있습니다.더 보기Hopium SA 기초 지표 요약Hopium의 순이익과 매출은 시가총액과 어떻게 비교됩니까?ALHPI 기초 통계시가총액€1.68m순이익 (TTM)€12.07m매출 (TTM)€10.10m0.1x주가수익비율(P/E)0.2x주가매출비율(P/S)ALHPI는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표ALHPI 손익계산서 (TTM)매출€10.10m매출원가€3.62m총이익€6.48m기타 비용-€5.58m순이익€12.07m최근 보고된 실적Dec 31, 2025다음 실적 발표일해당 없음주당순이익(EPS)0.032총이익률64.18%순이익률119.45%부채/자본 비율-41.8%ALHPI의 장기 실적은 어땠습니까?과거 실적 및 비교 보기View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/22 18:28종가2026/07/22 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Hopium SA는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공고 • May 21Hopium SA, Annual General Meeting, Jun 29, 2026Hopium SA, Annual General Meeting, Jun 29, 2026. Location: 38 rue laffitte, paris France
New Risk • Nov 15New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (51% average weekly change). Negative equity (-€36m). Earnings have declined by 15% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 34x increase in shares outstanding). Revenue is less than US$1m (€21k revenue, or US$24k). Market cap is less than US$10m (€1.58m market cap, or US$1.84m). Minor Risk Latest financial reports are more than 6 months old (reported December 2024 fiscal period end).
공고 • May 22Hopium SA, Annual General Meeting, Jun 06, 2025Hopium SA, Annual General Meeting, Jun 06, 2025. Location: u 30 rue du chateau des rentiers, paris France
Reported Earnings • May 05Full year 2024 earnings releasedFull year 2024 results: Net loss: €10.5m (loss narrowed 66% from FY 2023).
New Risk • Sep 16New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€9.2m free cash flow). Share price has been highly volatile over the past 3 months (21% average weekly change). Negative equity (-€36m). Revenue has declined by 100% over the past year. Shareholders have been substantially diluted in the past year (over 17x increase in shares outstanding). Revenue is less than US$1m (€13k revenue, or US$14k). Market cap is less than US$10m (€5.48m market cap, or US$6.08m). Minor Risk Latest financial reports are more than 6 months old (reported December 2023 fiscal period end).
공고 • May 26Hopium SA, Annual General Meeting, Jun 27, 2024Hopium SA, Annual General Meeting, Jun 27, 2024. Location: 7 rue auber, paris France
공고 • May 21Hopium SA, Annual General Meeting, Jun 29, 2026Hopium SA, Annual General Meeting, Jun 29, 2026. Location: 38 rue laffitte, paris France
New Risk • Nov 15New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (51% average weekly change). Negative equity (-€36m). Earnings have declined by 15% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 34x increase in shares outstanding). Revenue is less than US$1m (€21k revenue, or US$24k). Market cap is less than US$10m (€1.58m market cap, or US$1.84m). Minor Risk Latest financial reports are more than 6 months old (reported December 2024 fiscal period end).
공고 • May 22Hopium SA, Annual General Meeting, Jun 06, 2025Hopium SA, Annual General Meeting, Jun 06, 2025. Location: u 30 rue du chateau des rentiers, paris France
Reported Earnings • May 05Full year 2024 earnings releasedFull year 2024 results: Net loss: €10.5m (loss narrowed 66% from FY 2023).
New Risk • Sep 16New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€9.2m free cash flow). Share price has been highly volatile over the past 3 months (21% average weekly change). Negative equity (-€36m). Revenue has declined by 100% over the past year. Shareholders have been substantially diluted in the past year (over 17x increase in shares outstanding). Revenue is less than US$1m (€13k revenue, or US$14k). Market cap is less than US$10m (€5.48m market cap, or US$6.08m). Minor Risk Latest financial reports are more than 6 months old (reported December 2023 fiscal period end).
공고 • May 26Hopium SA, Annual General Meeting, Jun 27, 2024Hopium SA, Annual General Meeting, Jun 27, 2024. Location: 7 rue auber, paris France
Reported Earnings • Apr 24Full year 2023 earnings releasedFull year 2023 results: Net loss: €30.7m (loss widened 28% from FY 2022).
New Risk • Jan 25New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 118% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Negative equity (-€32m). Revenue has declined by 30% over the past year. Shareholders have been substantially diluted in the past year (118% increase in shares outstanding). Market cap is less than US$10m (€1.96m market cap, or US$2.14m). Minor Risk Revenue is less than US$5m (€2.0m revenue, or US$2.2m).
New Risk • Nov 10New major risk - Revenue and earnings growthRevenue has declined by 30% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Negative equity (-€32m). Revenue has declined by 30% over the past year. Market cap is less than US$10m (€1.95m market cap, or US$2.08m). Minor Risks Shareholders have been diluted in the past year (46% increase in shares outstanding). Revenue is less than US$5m (€2.0m revenue, or US$2.1m).
New Risk • Jul 31New major risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €9.08m (US$10.0m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Negative equity (-€10m). Minor Risks Shareholders have been diluted in the past year (11% increase in shares outstanding). Revenue is less than US$5m (€4.0m revenue, or US$4.4m). Market cap is less than US$100m (€9.08m market cap, or US$10.0m).
공고 • Dec 01Hopium Société anonyme (ENXTPA:MLHPI) acquired Young Innovative Company.Hopium Société anonyme (ENXTPA:MLHPI) acquired Young Innovative Company on November 30, 2021. Hopium Société anonyme (ENXTPA:MLHPI) completed the acquisition of Young Innovative Company on November 30, 2021.
공고 • Jun 18Hopium Unveils Its Hydrogen-powered Sedan Prototype And Opens The First 1000 Pre-ordersHopium unveiled its very first rolling prototype during the Viva Technology week in Paris. Announced in October 2020 and produced in record time in the Linas-Montlhéry test workshop, this vehicle called Alpha 0, certifies the reliability of the fuel cell system. After the design and architecture phases, followed by the implementation of the various components within the vehicle, the prototype was able to be evaluated and perfected through bench and track tests. With a speed of 200 km/h (124 mph), this test version already borders on the performance promised by the Hopium Machina in its final form. Alpha 0 also introduces for the first time the signature lighting, emblem of Hopium, whose shape is reminiscent of the stratification of hydrogen and the movement of waves on the surface of water. The reveal of this technological showcase is a key step in the manufacturer's roadmap and confirms its ability to achieve the goals that have been set and meet the high challenges. It is accompanied by the opening of an order book for the first 1,000 numbered units of Hopium Machina, whose reservation price is set at 410 euros, in reference to the spectral line of hydrogen. The Hopium teams are already fully committed in carrying out the next steps, aiming to produce Hopium Machina on an industrial scale, with a new rendez-vous expected in the first quarter of 2022.
